Charles Schwab Investment Management »

Arrivent Biopharma shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.5M 80k 18.55
2024-03-31 $1.4M 78k 17.86

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Us S (FNDA)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
FMR
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation

View all funds holding Arrivent Biopharma